Leadership

Shira is a pioneering force in the domain of drug delivery systems. She has been developing biopolymers for 25 years starting in the Israeli Technology Intelligence unit at the age of 18. Following her military service Shira completed her BSc. And MSc. cum laude at Tel Aviv University. Throughout her Ph.D. studies she received the distinguished Kraitman excellence scholarship, followed by a postdoc at Harvard Medical School. Following her postdoctoral work, Shira has gained experience in the pharma industry. Shira believes that bio-polymer based nanoparticles delivery system is the answer to gene therapy and will reshape the boundaries of drug delivery and patient care.

Eran boasts a multifaceted background that spans from the skies to the boardroom. Serving as an F-16 pilot for 15 years in the IDF, his dedication and precision are traits that have seamlessly transitioned into his entrepreneurial endeavors. His tenacious leadership style, characterized by vision and resilience, has been instrumental in steering his companies towards growth and prosperity. A proud graduate of Harvard’s Global Health Leadership Program, Eran has established himself as a seasoned healthcare entrepreneur. With a portfolio of 5 approved patents, his innovative spirit is undeniable. As the founder of XRHealth he further showcases his dedication to transforming healthcare. Under Eran’s guidance, his ventures don’t just flourish; they bloom, marking a legacy of sustained growth and impactful contributions.

Alysa has 17 years of clinical research expertise and a distinguished academic foundation including a recent alumna of the Global Health Leadership Program at Harvard Medical School. Over the last decade, she played an instrumental role in establishing the largest fully owned research site network in North America. With an astute business mind, Alysa’s capability in forging strategic partnerships has paved the network’s success and growth. Her unique ability to simplify complex challenges into actionable solutions marks a leadership style rooted in role modeling, setting standards of excellence that push teams to realize and harness their full potential, leading them towards unprecedented achievements.

Maximilien merges deep scientific insight with dynamic business execution. He holds a Ph.D. in Genetics from Harvard Medical School’s renowned George Church Lab, where he pioneered new genome synthesis techniques, and a bachelor’s in Biology from MIT. Along the way, he conducted research at NASA before honing his strategic skills at the leading global management consultancy BCG (Boston Consulting Group), guiding top biopharma clients on clinical trial acceleration and strategic optimization. Maximilien aligns scientific innovation with operational rigor, ensuring Envoya’s polymer and peptide platforms deliver tangible benefits for patients and partners. His approach brings clarity, agility, data-driven excellence, and a personal touch to the forefront of gene therapy development.